Investor Presentation
Filed with ASX · · 51 pages · English
In the deck
Story so far
Earlier from Memphasys
- Felix Japanese trial provides sperm preparation benefits
- 2024 Investor Presentation
- Felix TM System Sales Orders Accelerate in Japan
- AI-Port Update - Spring Field Trial Yields Positive Results
- Vitrolife distribution agreement expands into Canada and NZ
Later from Memphasys
- Dr David Ali appointed full-time Chief Executive Officer
- Animal activity update - oxidative stress measurement system
- Felix sales clinical trial and Oxidative Stress devel update
- Equine fertility study positions Felix as leading technology
- Response to ASX Query
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys